1. Home
  2. LBTYA vs ICUI Comparison

LBTYA vs ICUI Comparison

Compare LBTYA & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Global Ltd.

LBTYA

Liberty Global Ltd.

HOLD

Current Price

$11.71

Market Cap

3.6B

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$154.43

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBTYA
ICUI
Founded
2004
1984
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
LBTYA
ICUI
Price
$11.71
$154.43
Analyst Decision
Buy
Buy
Analyst Count
6
5
Target Price
$14.77
$179.50
AVG Volume (30 Days)
2.4M
246.5K
Earning Date
02-18-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,770,600,000.00
$2,320,363,000.00
Revenue This Year
$15.50
N/A
Revenue Next Year
$1.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
170.50
N/A
52 Week Low
$9.03
$107.00
52 Week High
$12.09
$165.17

Technical Indicators

Market Signals
Indicator
LBTYA
ICUI
Relative Strength Index (RSI) 64.76 54.98
Support Level $10.91 $148.71
Resistance Level $11.40 $155.60
Average True Range (ATR) 0.28 4.36
MACD 0.09 -0.47
Stochastic Oscillator 95.16 41.70

Price Performance

Historical Comparison
LBTYA
ICUI

About LBTYA Liberty Global Ltd.

Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: